Navigation Links
UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
Date:1/31/2008

Researchers at UCLAs Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.

The findings, published in the Feb. 1, 2008 issue of the Journal of Thoracic Oncology, may help oncologists personalize treatment, prescribing drugs they know patients will respond to and sparing them from therapies that wont work. Both drugs are taken in pill form once a day and result in fewer side effects than conventional treatments such as chemotherapy.

If the findings are confirmed in further studies, the personalized drug combination would offer an alternative therapy in a disease population in which new, more effective treatments are needed, said Dr. Steven Dubinett, a professor of pulmonary and critical care medicine and senior author of the study. This year alone, more than 213,000 Americans will be diagnosed with lung cancer. Of those, more than 160,000 will die.

We need good predictors of response to targeted therapy in lung cancer so individual patients receive the specific therapy that targets the particular molecular abnormalities of their tumors, said Dubinett, who also serves as director of the cancer centers Specialized Program of Research Excellence (SPORE) in lung cancer.

The findings grew out of a Phase I dose-escalation study of the drug combination in a small group of patients who had failed all other treatment options. The early phase study resulted in more patient responses than expected in people with advanced lung cancer, the most deadly stage of the disease. About 50 percent of patients in the study had tumors that decreased in size by more than 30 percent or had tumors that did not grow, a state called stable disease that is considered a positive outcome.

UCLA researchers studied tumor, blood and urine samples from the pa
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Penn researchers discover new target for preventing and treating flu
2. Researchers investigate links between prostate, cadmium, zinc
3. New nanotube findings by Stanford researchers give boost to potential biomedical applications
4. Researchers Map Paths Governing Neuron Function
5. Cold Spring Harbor Laboratory researchers race against time to save Tasmanian devils
6. Researchers at Peoria Pulmonary Associates to study airway bypass procedure for emphysema
7. Pain medicine meeting unites top researchers and clinicians
8. Researchers identify brains eureka circuitry
9. Researchers find relief for chronic pain
10. Researchers propose consumers buy yearly drug licenses as new way to pay for prescriptions
11. Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data ... new version of endpoint DLP developed specifically for Mac OS. , In June 2015, ... 100 IT and information security professionals had participated. The beta test done by the ...
(Date:9/1/2015)... ... September 01, 2015 , ... Agriculture innovation, urban farming, ... of the topics to be discussed at Seedstock’s 4th Annual Sustainable Agriculture Conference ... UC San Diego. , In addition to keynotes Pierre Sleiman, founder and CEO ...
(Date:9/1/2015)... ... 01, 2015 , ... Suzanne Bakken, PhD, RN, FAAN, FACMI ... of Medicine (IOM) of the National Academies. , She is the Alumni Professor ... A member of the Institute of Medicine since 2006, Bakken also currently co-directs ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, ... will be attending from across the country. All specialties will be represented. Attendees ...
(Date:9/1/2015)... ... September 01, 2015 , ... AdvantagePlusCaregivers.com® provides information on defining ... what to look for and expect when searching for resources, as well as ... Canoga Park, CA by CEO, Richard Weatherman and Co-Founder Piroska Zalkadi, AdvantagePlusCaregivers.com® grew ...
Breaking Medicine News(10 mins):Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2
... Rarely written about, seldom spoken,of, and often times ... astonishing 40% of women and 25% of men. Bulging, ... once were ordinary,tasks and activities into painful ordeals., ... the varicose veins significantly,affected her life and inhibited her ...
... The Otho S.A. Sprague Memorial Institute has awarded Rush ... first-of-its-kind patient-safety project. The pilot program will use Rushs ... avoid or modify activities and procedures that may have ... potential to serve as a model for similar mediation ...
... Feb. 22 Hazelden Foundation today,announced that Ellen ... down,from her position by April 4, 2008., ... an impressive record of accomplishment and a,legacy that ... come," said Norb,Conzemius, chairman of the Foundation Board ...
... More than $1.1 billion a year is spent on ... study reports the state has a rising number of people ... hunger. The MU Interdisciplinary Center for Food Security has released ... Missouri Hunger Atlas details the distribution of hunger in the ...
... Obesity is one of the greatest health risks for ... the rise. According to the Centers for Disease Control ... has tripled since 1980. To help Rush University Medical ... S.A. Sprague Memorial Institute has awarded Rush University Medical ...
... study found remission occurred faster, more often with ... (HealthDay News) -- Treating Crohn,s disease more aggressively ... team of researchers reports. , Using more than ... diagnosed with the disease was more effective in ...
Cached Medicine News:Health News:Beyond Vanity: New Treatment Brings Relief to Women After Years of Silent Suffering 2Health News:Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project 2Health News:Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project 3Health News:Hazelden President and CEO Ellen Breyer to Step Down April 4 2Health News:MU research team releases first Missouri Hunger Atlas 2Health News:Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention 2Health News:Aggressive Therapy for Crohn's Disease Produces Better Outcomes 2Health News:Aggressive Therapy for Crohn's Disease Produces Better Outcomes 3
(Date:9/1/2015)... BAKERSFIELD, Calif. , Sept. 1, 2015 /PRNewswire/ ... Chronic Care Management (CCM) and Drug Adherence m ... monitoring help automate the process of non face-to-face ... "With this new release of our apps, ... care management services along with our ONCHIT certified ...
(Date:9/1/2015)... , Sept. 1, 2015 CytRx Corporation ... development company specializing in oncology, today announced that ... Executive Officer, and David Haen , Vice ... present a corporate overview at two significant investment ... and healthcare industries: the FBR & Co. Second ...
(Date:9/1/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rd9jbr/introduction_to ) has ... Veterinary Pharmacovigilance (London, UK - September 23-24)" ... course has been designed to provide basis training ... Veterinary Pharmacovigilance. New entrants, support staff we well ... of veterinay drug safety will benefit from the ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
... Despite concerns from public health officials, influenza antiviral drugs were ... analysis presented recently at the Academy of Managed Care Pharmacy,s 22nd Annual ... leader in pharmacy benefit management. , ... For the study, researchers from Prime and one of its ...
... United Kingdom , May 20 Today, in a ... cancer treatment drugs on a permanent ,not for profit, basis potentially ... cancer killer of women in the UK and as part of ... of Iressa, used to treat lung cancer, is now available for ...
Cached Medicine Technology:New Prime Therapeutics Study Finds Antiviral Medications Were Not Hoarded During H1N1 Flu Season 2In a World First, Asda Announces 'Not for Profit' Price on All Cancer Treatment Drugs 2In a World First, Asda Announces 'Not for Profit' Price on All Cancer Treatment Drugs 3
Rad-5v signal extraction pulse oximeter™...
... The Avant® 4000 System with ... wired connections while ensuring reliable and ... all in a small package. The ... data to a small tabletop display, ...
The Dolphin Medical 2150 Pulse Oximeter consists of the Dolphin ONE OEM 701 Module technology, (1) extension cable, and (1) oximetry sensor to non-invasively calculate the functional saturation of ar...
Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
Medicine Products: